AVITA Medical (RCEL) Cash & Current Investments (2018 - 2026)
AVITA Medical's (RCEL) quarterly Cash & Current Investments came in at $16.3 million in Q4 2025, down 54.46% YoY from $35.9 million in Q4 2024, and down 29.9% on a QoQ basis from $23.3 million in Q3 2025.
AVITA Medical (RCEL) Cash & Current Investments (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Cash & Current Investments data on file, last reported at $16.3 million in Q4 2025.
- Quarterly Cash & Current Investments fell 54.46% year-over-year to $16.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.3 million (down 54.46% YoY) and the FY2025 annual result came in at $16.3 million, down 54.46% from the prior year.
- Cash & Current Investments slipped to $16.3 million in Q4 2025, from $23.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $115.1 million in Q1 2021 to a low of $14.1 million in Q2 2025.
- A 5-year average of $63.2 million and a median of $69.2 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 49.98% — and 2025, when it tumbled 70.31%.
- Tracing RCEL's Cash & Current Investments over 5 years: stood at $85.4 million in 2021, then dropped by 11.81% to $75.3 million in 2022, then increased by 4.07% to $78.3 million in 2023, then sank by 54.19% to $35.9 million in 2024, then tumbled by 54.46% to $16.3 million in 2025.
- The last three Cash & Current Investments figures came in at $16.3 million (Q4 2025), $23.3 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | AVITA Medical | 312.73 Mn | 301.59 Mn | 17.77 Mn | 11.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.14 Mn |
| Dec 31, 2025 | 16.34 Mn |
| Sep 30, 2025 | 23.31 Mn |
| Jun 30, 2025 | 14.07 Mn |
| Mar 31, 2025 | 25.82 Mn |
| Dec 31, 2024 | 35.89 Mn |
| Sep 30, 2024 | 39.07 Mn |
| Jun 30, 2024 | 47.40 Mn |
| Mar 31, 2024 | 68.18 Mn |
| Dec 31, 2023 | 78.34 Mn |
| Sep 30, 2023 | 55.66 Mn |
| Jun 30, 2023 | 60.26 Mn |
| Mar 31, 2023 | 70.20 Mn |
| Dec 31, 2022 | 75.28 Mn |
| Sep 30, 2022 | 84.17 Mn |
| Jun 30, 2022 | 84.56 Mn |
| Mar 31, 2022 | 83.57 Mn |
| Dec 31, 2021 | 85.36 Mn |
| Sep 30, 2021 | 90.39 Mn |
| Jun 30, 2021 | 110.75 Mn |